About Daclatasvir Dihydrochloride
Class: | Antiviral agent, specifically a direct-acting antiviral (DAA) for the treatment of hepatitis C virus (HCV)
Use: | Treatment of chronic hepatitis C in combination with other antiviral agents
Adult dose: | 60 mg orally once daily, in combination with other HCV medications
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age
Side effects: | Fatigue, headache, nausea, diarrhea, insomnia, and elevated liver enzymes
Contraindications: | C
Contraindications & Precautions
Co-administration with strong inducers of CYP3A (e.g., rifampin, St. John's Wort); hypersensitivity to daclatasvir or any component of the formulation
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.